Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin

AIMS: Indisulam and carboplatin have shown synergistic activity in preclinical studies. In a dose escalation study of the combination, a treatment delay was frequently required in a 3-weekly regimen to allow recovery from myelosuppression from previous cycles. A 4-weekly regimen was better tolerated...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Zandvliet, Anthe S, Schellens, Jan H M, Dittrich, Christian, Wanders, Jantien, Beijnen, Jos H, Huitema, Alwin D R
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Science Inc 2008
Teme:
Pharmacokinetic Dynamic Relationships
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2561111/
https://ncbi.nlm.nih.gov/pubmed/18637887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2008.03230.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items